Enhancing Outcomes in Chronic Fibrotic Interstitial Lung Disease Through Aggressive Management of Nintedanib-Induced Adverse Drug Reactions: A Retrospective Analysis
Aggressive management of ADRs may enhance patient tolerance to nintedanib, potentially prolonging treatment duration and improving outcomes in chronic fibrotic ILD.
Authors
- Kuo-Tung Huang (ORCID: https://orcid.org/0000-0002-8363-8151)
- Meng‐Yun Tsai (ORCID: https://orcid.org/0000-0002-0122-0932)
- Chien‐Chang Liao (ORCID: https://orcid.org/0000-0001-6694-0730)
- Yu-Ping Chang (ORCID: https://orcid.org/0000-0002-2535-5954)
- Yu-Ting Lin (ORCID: https://orcid.org/0000-0003-4394-811X)
- Meng‐Chih Lin (ORCID: https://orcid.org/0000-0001-7777-9356)
- Yuwen Chang
- Chien‐Hao Lai
Institutions
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Kaohsiung Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1007/s40801-024-00443-0
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00